Yilun Liu, MBA

Mar 31, 2021View PDF

Mr. Liu is primarily responsible for participating in formulating our Company’s corporate and business strategies.


Mr. Liu has been an executive director at Boyu Capital Group Management Ltd., since April 2018 and was deeply involved in Boyu’s investment of the Company’s seriesB financing. Mr. Liu has been a director of Keymed Biosciences Inc., a company whose shares are listed on the Main Board of the Stock Exchange (Stock Code: 2162), since March 3, 2021, and was re-designated as a non-executive director on April 3, 2021.


Mr. Liu received his bachelor of science degree in marketing from Fudan University in the PRC in July 2009. He then obtained his master of business administration degree from Columbia Business School in May 2015.